Chronic Rhinosinusitis with Nasal Polyps Navigating New Pathways to Better Patient Outcomes

Chronic inflammatory diseases of the upper and lower airways, especially CRSwNP and asthma, have been tied to significant risks and burdens for affected patients and frequently require close coordinated multidisciplinary care. Targeted agents designed to interrupt inflammatory cytokine signaling have been examined in clinical trials and evidence suggests these options can provide a range of benefits in patients with CRSwNP and related comorbidities. During this interactive activity, expert faculty will provide multidisciplinary insights related to diagnosis and management of patients with CRSwNP. Topics will include CRSwNP symptom presentation and diagnosis, overlapping pathophysiologic processes in chronic inflammatory airway diseases, the rationale and evidence behind biologic therapies, and integrated therapeutic strategies to achieve long-term global disease control. Please join our expert faculty and a patient with CRSwNP on this journey.